TWO · 6917.TWO
Andros Pharmaceuticals Co.,Ltd
NT$32.25-NT$0.90 (-2.71%)
Andros Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.82% below the high.
Loading market information…
TWO · 6572.TWO · TWD
Stock price
Quote as of Oct 30, 2026, 06:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
PlexBio Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 59.81% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:43 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$32.25-NT$0.90 (-2.71%)
Andros Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.82% below the high.
NT$30.15NT$0.00 (0.0%)
Concord Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.75% below the high.
NT$15.40-NT$0.65 (-4.05%)
AmCad BioMed Corporation’s quoted price sits in the upper half of its reported 52-week range, 18.3% below the high.
NT$31.20-NT$1.80 (-5.45%)
Ttbio Corp.’s quoted price sits in the lower half of its reported 52-week range, 48.17% below the high.
NT$15.85-NT$0.20 (-1.25%)
Radiant Innovation Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.7% below the high.
NT$18.65NT$0.00 (0.0%)
TFBS Bioscience Inc.’s quoted price sits in the lower half of its reported 52-week range, 33.03% below the high.
NT$16.90+NT$0.40 (+2.42%)
SynCore Biotechnology Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.32% below the high.
NT$6.22-NT$0.18 (-2.81%)
General Biologicals Corporation’s quoted price sits in the lower half of its reported 52-week range, 64.05% below the high.
